170 related articles for article (PubMed ID: 38277301)
1. Break Down of the Complexity and Inconsistency Between Levels of Matriglycan and Disease Phenotype in FKRP-Related Dystroglycanopathies: A Review and Model of Interpretation.
Lu QL; Holbrook MC; Cataldi MP; Blaeser A
J Neuromuscul Dis; 2024; 11(2):275-284. PubMed ID: 38277301
[TBL] [Abstract][Full Text] [Related]
2. Revertant Phenomenon in DMD and LGMD2I and Its Therapeutic Implications: A Review of Study Under Mentorship of Terrence Partridge.
Lu QL
J Neuromuscul Dis; 2021; 8(s2):S359-S367. PubMed ID: 34151854
[TBL] [Abstract][Full Text] [Related]
3. Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies.
Chan YM; Keramaris-Vrantsis E; Lidov HG; Norton JH; Zinchenko N; Gruber HE; Thresher R; Blake DJ; Ashar J; Rosenfeld J; Lu QL
Hum Mol Genet; 2010 Oct; 19(20):3995-4006. PubMed ID: 20675713
[TBL] [Abstract][Full Text] [Related]
4. Ribitol dose-dependently enhances matriglycan expression and improves muscle function with prolonged life span in limb girdle muscular dystrophy 2I mouse model.
Wu B; Drains M; Shah SN; Lu PJ; Leroy V; Killilee J; Rawls R; Tucker JD; Blaeser A; Lu QL
PLoS One; 2022; 17(12):e0278482. PubMed ID: 36454905
[TBL] [Abstract][Full Text] [Related]
5. Ribitol enhances matriglycan of α-dystroglycan in breast cancer cells without affecting cell growth.
Lu PJ; Tucker JD; Branch EK; Guo F; Blaeser AR; Lu QL
Sci Rep; 2020 Mar; 10(1):4935. PubMed ID: 32188898
[TBL] [Abstract][Full Text] [Related]
6. NAD+ improves neuromuscular development in a zebrafish model of FKRP-associated dystroglycanopathy.
Bailey EC; Alrowaished SS; Kilroy EA; Crooks ES; Drinkert DM; Karunasiri CM; Belanger JJ; Khalil A; Kelley JB; Henry CA
Skelet Muscle; 2019 Aug; 9(1):21. PubMed ID: 31391079
[TBL] [Abstract][Full Text] [Related]
7. Mouse models of fukutin-related protein mutations show a wide range of disease phenotypes.
Blaeser A; Keramaris E; Chan YM; Sparks S; Cowley D; Xiao X; Lu QL
Hum Genet; 2013 Aug; 132(8):923-34. PubMed ID: 23591631
[TBL] [Abstract][Full Text] [Related]
8. Expression of glycosylated α-dystroglycan in newborn skeletal and cardiac muscles of fukutin related protein (FKRP) mutant mice.
Keramaris E; Lu PJ; Tucker J; Lu QL
Muscle Nerve; 2017 Apr; 55(4):582-590. PubMed ID: 27515093
[TBL] [Abstract][Full Text] [Related]
9. Improved efficacy of FKRP AAV gene therapy by combination with ribitol treatment for LGMD2I.
Cataldi MP; Vannoy CH; Blaeser A; Tucker JD; Leroy V; Rawls R; Killilee J; Holbrook MC; Lu QL
Mol Ther; 2023 Dec; 31(12):3478-3489. PubMed ID: 37919902
[TBL] [Abstract][Full Text] [Related]
10. Prenatal muscle development in a mouse model for the secondary dystroglycanopathies.
Kim J; Hopkinson M; Kavishwar M; Fernandez-Fuente M; Brown SC
Skelet Muscle; 2016; 6():3. PubMed ID: 26900448
[TBL] [Abstract][Full Text] [Related]
11. NAD+ enhances ribitol and ribose rescue of α-dystroglycan functional glycosylation in human FKRP-mutant myotubes.
Ortiz-Cordero C; Magli A; Dhoke NR; Kuebler T; Selvaraj S; Oliveira NA; Zhou H; Sham YY; Bang AG; Perlingeiro RC
Elife; 2021 Jan; 10():. PubMed ID: 33513091
[TBL] [Abstract][Full Text] [Related]
12. Restoration of Functional Glycosylation of α-Dystroglycan in FKRP Mutant Mice Is Associated with Muscle Regeneration.
Awano H; Blaeser A; Keramaris E; Xu L; Tucker J; Wu B; Lu P; Lu QL
Am J Pathol; 2015 Jul; 185(7):2025-37. PubMed ID: 25976249
[TBL] [Abstract][Full Text] [Related]
13. Expression in retinal neurons of fukutin and FKRP, the protein products of two dystroglycanopathy-causative genes.
Haro C; Uribe ML; Quereda C; Cruces J; Martín-Nieto J
Mol Vis; 2018; 24():43-58. PubMed ID: 29416295
[TBL] [Abstract][Full Text] [Related]
14. Matriglycan maintains t-tubule structural integrity in cardiac muscle.
Hord JM; Anderson ME; Prouty SJ; Melton S; Gastel Z; Zimmerman K; Weiss RM; Campbell KP
Proc Natl Acad Sci U S A; 2024 May; 121(22):e2402890121. PubMed ID: 38771868
[TBL] [Abstract][Full Text] [Related]
15. Dystroglycanopathy muscles lacking functional glycosylation of alpha-dystroglycan retain regeneration capacity.
Awano H; Blaeser A; Wu B; Lu P; Keramaris-Vrantsis E; Lu Q
Neuromuscul Disord; 2015 Jun; 25(6):474-84. PubMed ID: 25937147
[TBL] [Abstract][Full Text] [Related]
16. ISPD Overexpression Enhances Ribitol-Induced Glycosylation of α-Dystroglycan in Dystrophic FKRP Mutant Mice.
Cataldi MP; Blaeser A; Lu P; Leroy V; Lu QL
Mol Ther Methods Clin Dev; 2020 Jun; 17():271-280. PubMed ID: 31988979
[TBL] [Abstract][Full Text] [Related]
17. FKRP mutations cause congenital muscular dystrophy 1C and limb-girdle muscular dystrophy 2I in Asian patients.
Awano H; Saito Y; Shimizu M; Sekiguchi K; Niijima S; Matsuo M; Maegaki Y; Izumi I; Kikuchi C; Ishibashi M; Okazaki T; Komaki H; Iijima K; Nishino I
J Clin Neurosci; 2021 Oct; 92():215-221. PubMed ID: 34509255
[TBL] [Abstract][Full Text] [Related]
18. Abnormal vascular development in zebrafish models for fukutin and FKRP deficiency.
Wood AJ; Müller JS; Jepson CD; Laval SH; Lochmüller H; Bushby K; Barresi R; Straub V
Hum Mol Genet; 2011 Dec; 20(24):4879-90. PubMed ID: 21926082
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic Spectrum of α-Dystroglycanopathies Associated With the c.919T>a Variant in the FKRP Gene in Humans and Mice.
Brown SC; Fernandez-Fuente M; Muntoni F; Vissing J
J Neuropathol Exp Neurol; 2020 Dec; 79(12):1257-1264. PubMed ID: 33051673
[TBL] [Abstract][Full Text] [Related]
20. Adeno-associated virus-mediated overexpression of LARGE rescues α-dystroglycan function in dystrophic mice with mutations in the fukutin-related protein.
Vannoy CH; Xu L; Keramaris E; Lu P; Xiao X; Lu QL
Hum Gene Ther Methods; 2014 Jun; 25(3):187-96. PubMed ID: 24635668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
